Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 29-34

  Lebeurier, Isabelle ^a   Basara, Nada ^a,c   Aïdoudi, Sallouha ^a   Amiral, Jean ^b   Caen, Jacques P ^a   Han, Zhong Chao ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Laboratoire Serbio   (France)

^c Institut d'Hématologie

Author keywords

Heparin; Megakaryocytopoiesis; PF4 related peptides; Platelets

Indexed keywords

HEPARIN; NADROPARIN; SYNTHETIC PEPTIDE; THROMBOCYTE FACTOR 4;

ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEMATOPOIESIS; MALE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; HEPARIN; MALE; MEGAKARYOCYTES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLATELET FACTOR 4;

EID: 0030032389     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.296828.x     Document Type: Article

References (32)

1. Amiral, J., Bridey, F., Wolf, M., Boyer-Neumann, C., Fressinaud, E., Vissac, A.M., Peynaud-Debayle, E., Dreyfus, M. & Meyer, D. (1995) Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thrombosis and Haemostasis, 71, 21-28.
2. Barber, A.J., Käser-Glanzmann, R., Jakahova, M. & Luscher, E.F. (1972) Characterization of chondroitin sulfate proteoglycan carrier for heparin-neutralizing activity (PF4) released from human blood platelets. Biochimica et Biophysica Acta, 286, 312-329.
3. Carlo-Stella, C., Cazzola, M., Gasner, A., Barosi, G., Dezza, L., Meloni, F., Pedrazzoli, P., Hoelzer, D. & Ascari, E. (1987) Effects of recombinant alpha and gamma interferon on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM. CFU-MK, BFU-E and CFU-GM) from patients with myeloid metaplasia. Blood, 70, 1014-1019.
4. Conley, L.C., Hartmann, R.C. & Lalley, J.S. (1948) The relationship of heparin activity to platelet concentration. Proceedings of the Society for Experimental Biology and Medicine, 69, 284-286.
5. Cowan, S.W., Bakshi, E.N., Machin, K.J. & Isaacs, N.W. (1986) Binding of heparin to human platelet factor 4. Biochemistry Journal, 234, 485-488.
6. Deuel, T.F., Keim, P.S., Farmer, M. & Heinrikson, R.L. (1977) Human platelet factor 4: complete amino acid sequence. Proceedings of the National Academy of Sciences of the United States of America, 74, 2256-2258.
7. Gewirtz, A.M., Calabretta, B., Rucinski, B., Niewiarowski, S. & Xu, W.Y. (1989) Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. Journal of Clinical Investigation, 81, 1477-1486.
8. Gupta, S.K. & Singh, J.P. (1994) Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. Journal of Cell Biology, 127, 1121-1127.
9. Han, Z.C., Bellucci, S., Bodevin, E., Wan, H.Y., Shen, Z.X. & Caen, J.P. (1991) In vivo inhibition of megakaryocyte and platelet factor 4 in mice. Comptes Rendus de l'Académie des Sciences de Paris, 313, 553-558.
10. Han, Z.C., Bellucci, S., Tenza, D. & Caen, J.P. (1990a) Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. British Journal of Haematology, 74, 395-401.
11. Han, Z.C., Bellucci, S., Walz, A., Baggiolini, M. & Caen, J.P. (1990b) Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide III (CTAP III). International Journal of Cell Cloning, 8, 253-259.
12. Han, Z.C., Bellucci, S., Wan, H. & Caen, J.P. (1992a) New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor β1. British Journal of Haematology, 81, 1-5.
13. Han, Z.C., Brière, J., Abgrall, J.F., Le Gall, G., Parent, D. & Sensebe, L. (1987) Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation. Journal of Biological Regulators and Homeostatic Agents, 1, 195-200.
14. Han, Z.C., Lebeurier, I. & Caen, J.P. (1993) Negative regulation of megakaryocytopoiesis. The Negative Regulation of Hematopoiesis (ed. by M. Guigon et al), pp. 225-233. Colloque INSERM/John Libbey Eurotext.
15. Han, Z.C., Maurer, A.M., Bellucci, S., Wan, H.Y., Kroviarski, Y., Bertrand, O. & Caen, J.P. (1992b) Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4. Journal of Laboratory and Clinical Medicine, 120, 645-660.
16. Han, Z.C., Sensebe, L., Abgrall, J.F. & Briere, J. (1990c) Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood, 75, 1234-1239.
17. Handin, R.I. & Cohen, H.J. (1976) Purification and binding properties of human platelet factor 4. Journal of Biological Chemistry, 251, 4273-4282.
18. Hermodson, M., Schmer, G. & Kurachi, K. (1977) Characterization and primary amino acid sequence of human platelet factor 4. Journal of Biological Chemistry, 252, 6276-6279.
19. Hoffman, R. (1989) Regulation of megakaryocytopoiesis. Blood, 74, 1196-1212.
20. Holt, J.C., Harris, M.E., Holt, A.M., Lange, E., Henschen, A. & Niewiarowski, S. (1986) Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and β-thromboglobulin. Biochemistry, 25, 1988-1996.
21. Ishibashi, T., Miller, S. & Burstein, S.A. (1987) Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood, 69, 1737-1741.
22. Kuter, D.J., Gminski, D.M. & Rosenberg, R.D. (1992) Transforming growth factor β inhibits megakaryocyte growth and endomitosis. Blood, 79, 619-626.
23. Mayo, K.H., Barker, S., Kuranda, M.J., Hunt, A.J., Myers, J.A. & Maione, T.E. (1992) Molten globule monomer to condensed dimer: role of disulfide bonds in platelet factor 4 folding and subunit association. Biochemistry, 31, 12255-12265.
24. Mayo, K.H. & Chen, M.J. (1989) Human platelet factor 4 monomerdimer-tetramer equilibria investigated by H-NMR spectroscopy. Biochemistry, 28, 9469-9478.
25. Moore, S., Pepper, D.S. & Cash, J.D. (1975) Platelet antiheparin activity: the isolation and characterization of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochimica et Biophysica Acta, 379, 370-384.
26. Moses, H.L., Yang, E.Y. & Pietenpol, J.A. (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63, 245-247.
27. Niewiarowski, S. & Thomas, D.P. (1969) Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature, 222, 1269-1270.
28. Piao, Y.F., Ichijo, H., Miyagawa, K., Ohashi, H., Takaku, F. & Miyazono, K. (1990) Latent form of transforming growth factor-β1 acts as a potent growth inhibitor on a human erythroleukemia cell line. Biochemical and Biophysical Research Communications, 167, 27-32.
29. Rybak, M.E., Gimbrone, M.A., Davies, P.F., Jr & Handin, R.I. (1989) Interaction of platelet factor 4 with cultured vascular endothelial cells. Blood, 73, 1534-1539.
30. Shen, Z.X., Basara, N., Xi, X.D., Caen, J.P., Maffrand, J.P., Pascal, M., Petitou, M., Lormeau, J.C. & Han, Z.C. (1994) Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice. British Journal of Haematology, 88, 608-612.
31. Walz, D.A., Wu, V.Y., DeLamo, R., Dene, H. & McCoy, L.E. (1977) Primary structure of human platelet factor 4. Thrombosis Research, 11, 892-898.
32. Zhang, X., Chen, L., Bancroft, D., Lai, C.K. & Maione, T.E. (1994) Crystal structure of recombinant human platelet factor 4. Biochemistry, 33, 8361-8366.